CClinicalTrials.gg
CompletedNCT02223585Updated Apr 20, 2015

Gut Microbiota and Proteins Intake

An interventional study of Animal-based protein diet and Vegan-based protein diet in Healthy, sponsored by Société des Produits Nestlé (SPN). Completed at 1 site in Switzerland. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-04-20.

Sponsored by Société des Produits Nestlé (SPN) · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
40
Ages
18 Years to 55 Years
Sex
All
01

Study summary

Gut microbiota are involved in the regulation of mammalian metabolic pathways through host-microbiota metabolic, signaling, and immune-inflammatory interactions that physiologically connect the gut, liver, brain, and other organs. Correlation of these metabotypes with gut microbial profiles facilitates deciphering inherent host-microbe relationships.

Microbiome sequencing have generated novel insights into the role of gut microbial composition in health and disease, but are limited in addressing the microbial contribution to host metabolism and the gut microbial dysbiosis in disease.

This is an exploratory trial, aiming to examine how gut microbial conditions determine response to dietary challenge by measuring urine, plasma and stool metabolites resulting from metabolism of protein, polyamines and bile acids in combination with stool bacterial composition. The focus of this trial is to evaluate impact of protein based food challenges, based on cross-over design of two diet challenges of animal and vegan protein sources.

02

Conditions studied

  • Healthy

Keywords

  • Gut microbial
  • response
  • to protein-based
  • diet
  • challenges
  • population
03

In context

Lead sponsor

Société des Produits Nestlé (SPN) is the lead sponsor of 314 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Caucasian
  • Regular bowl movement (at least once every 1-2 days)
  • Between 18 and 55 years old
  • BMI between 18.5 and 27 kg/m2 (inclusive)
  • Willing and able to sign written informed consent prior to trial entry

Exclusion criteria

Exclusion Criteria:

  • Clinically relevant digestive, renal or metabolic disease, as determined by the medical (screening) visit and a standard blood chemistry analysis (glucose, total cholesterol, LDL, HDL, triglycerides, Aspartate aminotransferase (ASAT), Alanine aminotransferase (ALAT), gamma glutamyl transferase (Gamma-GT), C reactive protein (CRP), creatinine)
  • Undergoing regular medical treatment, pain-killers accepted, based on the medical questionnaire
  • Special diets: vegetarian, high protein or weight loss program (anamnesis)
  • Pregnancy (anamnesis)
  • Food allergy
  • Participation in a cholesterol management program with functional foods like food supplement enriched in omega-3 fatty acids, dairy products enriched with phytosterols (margarines, yoghurts), evaluated during the medical visit
  • Practicing more than 5 moderated physical activity per week
  • Smoker (anamnesis)
  • Have a high alcohol consumption (more than 2 drinks/day) (anamnesis)
  • Consumption of illicit drugs, (anamnesis)
  • Having given blood within the last month, or willing to make a blood donation until one month following the end of the study
  • Subject who cannot be expected to comply with the study procedures, including consuming the test products.
  • Currently participating or having participated in another clinical trial during the last month prior to the beginning of this study.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Cross-over single arm

    Other: Animal-based protein diet · Other: Vegan-based protein diet

Interventions

  • OtherAnimal-based protein diet
  • OtherVegan-based protein diet
06

What researchers measure

Primary outcomes

  1. Intra-individual plasma, stools, and urine omics to acute controlled feeding

    Metabonomics on fasting blood, urine, and stools and microbiota composition by 1. defining individual baseline (3-Day baseline before start of diet challenges); 2. Examining effect of the dietary challenges (3-Day diet challenge vs. Baseline); 3. Examining global dietary effect (baseline after challenge 2 vs. baseline after challenge 1) and stability of dietary effect (3rd day of each diet challenge vs. baseline after the challenge)

    Time frame: 3-Day baseline, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout

  2. Intra-individual plasma biochemistry response to acute controlled feeding

    To evaluate effect of the dietary challenges (Day 3 vs Day1 of each diet challenge), the global dietary effect (baseline after challenge 2 vs. the baseline after challenge 1, Day 1 of diet challenge 1), stability of the dietary effect (3rd day of each diet challenge vs. baseline after the challenge)

    Time frame: Day 1 and 3 of diet challenge 1, 1-Day baseline after challenge 1 washout, Day 1 and 3 of diet challenge 2, 1-Day baseline after challenge 2 washout

Secondary outcomes

  1. Subject's omics adaptation phase to a controlled diet Subject's omics adaptation phase to a controlled diet

    Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition

    Time frame: 3-Day diet challenge 1 and 2

  2. Comparison of intra-individual daytime plasma response amongst diets and free living restricted diets

    Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition

    Time frame: 3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout

  3. Pairing of gut microbial metabolite to gut microbial composition to generate concept on gut functional system to be followed-up in future studies

    Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition

    Time frame: 3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout

  4. Pairing dietary intake and preferences with subjects response in Omics endpoints

    Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition and 3- Days dietary recall during diet challenges and food frequency questionnaire at baseline before start of diet challenges

    Time frame: 3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout

07

Study locations

1 site
  • Metabolic Unit, Clinical Development Unit, Nestec
    Lausanne, 1000, Switzerland
08

References and documents

Publications

  • Draper CF, Tini G, Vassallo I, Godin JP, Su M, Jia W, Beaumont M, Moco S, Martin FP. Vegan and Animal Meal Composition and Timing Influence Glucose and Lipid Related Postprandial Metabolic Profiles. Mol Nutr Food Res. 2019 Mar;63(5):e1800568. doi: 10.1002/mnfr.201800568. Epub 2019 Feb 21. PubMed 30724465 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 20, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02223585
Lead sponsor
Société des Produits Nestlé (SPN)
Responsible party
Sponsor
First posted
Aug 22, 2014
Start date
Oct 2014
Primary completion
Mar 2015
Completion
Mar 2015
Last update
Apr 20, 2015

Study contacts

Maurice Beaumont, MD, PhD, PD Dr
principal investigator · Metabolic Unit, Clinical Development Unit, Nestec

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion